Taking down the talking cure

Review of The Therapy Industry: the Irresistible Rise of the Talking Cure, and Why it Doesn’t Work By Paul Moloney, Pluto Press, 2013 Everyone sings the praises of talking therapy these days. A myriad of therapies, each with their own logic and rationale and a technical sounding acronym, claim to cure an increasingly diverse range…

‘Psychiatric prejudice’- a new way of silencing criticism

‘Psychiatric prejudice’ is a term being bandied about these days, mainly by aggrieved psychiatrists who feel that psychiatry is not being given equal status with other medical specialities. Ordinary people, other doctors and medical students are all prejudiced because they do not appreciate that psychiatry is a proper medical activity, and critics of psychiatry are…

‘Angels and demons’: the politics of psychoactive drugs

The FIAT (Financial Incentives for Adherence Trial) study, published last year, highlights the paradoxical nature of our current attitude to the use mind-altering drugs. In this randomised controlled trial people with ‘psychotic disorders’ were paid £15 a time to take an injection of an ‘antipsychotic’ drug (1). The payment increased rates of compliance only marginally,…

Psychiatry has its head in the sand: Royal College of Psychiatrists rejects discussion of crucial research on antipsychotics

Two pieces of research have been published over the last two years that should prompt a major reorientation of the treatment of schizophrenia and psychosis, and a fundamental reappraisal of the use of antipsychotic drugs in general.  Put together, these studies suggest that the standard approach to treating serious mental health problems may cause more…